Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...

Feel Therapeutics Granted US Patent for its Emotion Detection Technology SAN FRANCISCO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading digital precision medicine company in mental health, today announced the recent granting by the United States...

Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...

Frontiers in Digital Health Publication Presents Feel Therapeutics Program as a New Strategy for Effectively Monitoring and Improving Anxiety and Depression SAN FRANCISCO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leader in digital precision medicine for Mental Health, today announced the publication in Frontiers in Digital Health of a...